A former drug addict said that ketamine should be a Class A drug as data revealed the number of people being treated in ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results